Ignite Creation Date:
2024-05-05 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 9:28 AM
Study NCT ID:
NCT00398567
Status:
COMPLETED
Last Update Posted:
2018-07-24
First Post:
2006-11-09
Brief Title:
A Phase 12 Study Of HKI-272 Neratinib in Combination With Trastuzumab Herceptin In Subjects With Advanced Breast Cancer
Sponsor:
Organization:
Puma Biotechnology Inc